Kolexia
Bougneres Pierre-François
Pédiatrie
Cabinet libéral
Boulogne-Billancourt, France
100 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 1 Diabète Troubles de la croissance Obésité Obésité morbide Ostéochondrodysplasies Perte de poids Dysostoses Adrénoleucodystrophie

Industries

Sandoz
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Increased CpG methylation at the CDH1 locus in inflamed ileal mucosa of patients with Crohn disease.
Clinical epigenetics   14 février 2024
Early varicella infection is associated with a delayed onset of childhood type 1 diabetes.
Diabetes & metabolism   25 septembre 2022
Long-Term Disease Prevention with a Gene Therapy Targeting Oligodendrocytes in a Mouse Model of Adrenomyeloneuropathy.
Human gene therapy   18 juillet 2022
The Half-Empty Glass of GH Treatment in Dyschondrosteosis.
Hormone research in paediatrics   28 juin 2022
Differentially methylated CpGs in response to growth hormone administration in children with idiopathic short stature.
Clinical epigenetics   18 mai 2022
Letter to the Editor from Bougnères: "Reproductive Hormone Concentrations and Associated Anatomical Responses: Does Soy Formula Affect Minipuberty in Boys?".
The Journal of clinical endocrinology and metabolism   07 février 2022
Correction of a knock-in mouse model of acrodysostosis with gene therapy using a rAAV9-CAG-human PRKAR1A vector.
Gene therapy   01 octobre 2021
Letter to the Editor: "A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness".
The Journal of clinical endocrinology and metabolism   26 août 2021
Long-Term Follow-Up of Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
Human gene therapy   04 mai 2021
Design of a Phase 1/2 Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy in Adults With Classic Congenital Adrenal Hyperplasia (CAH) Due to 21-hydroxylase Deficiency Through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene
ENDO 2021 Abstracts Annual Meeting of the Endocrine Society   03 mai 2021